Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Large Cap Biopharmaceuticals Performance
May 20, 2024
Tickers
AZN
BIIB
BMY
GILD
Tags
Stocks / Equities
Pharma/Biotech
ETFs
From
TalkMarkets
A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In
May 20, 2024
Tickers
ABCL
ABSI
EXAI
RXRX
Tags
Technology
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week in Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
May 19, 2024
Tickers
SLGL
TAK
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
For Biotech Stocks To Move Higher, This Must Move Lower
May 15, 2024
Tickers
IBB
XBI
Tags
Market News
ETFs
Pharma/Biotech
From
TalkMarkets
Chart Of The Day: Kewaunee Scientific - New All Time High
May 14, 2024
Tickers
KEQU
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Amid Biotech Pitfalls, ImmunityBio Has Outperformed NVDA In The Last 3 Months
May 13, 2024
Tickers
IBRX
LEGN
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
May 13, 2024
Tickers
ABCL
ABSI
ATAI
EXAI
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Healthcare And Biotech Investing 101: What You Need To Know.
May 13, 2024
Tickers
ABBV
LLY
MRK
REGN
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
TalkMarkets
Week In Review: Sciwind, Sino Biological And Biocytogen Announce Deals
May 11, 2024
Tickers
DHR
IVBXF
WUXIF
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
A Look At Pharma ETFs Post Q1 Earnings
May 07, 2024
Tickers
FTXH
IHE
JNJ
MRK
Tags
Pharma/Biotech
ETFs
Market News
From
TalkMarkets
Tuesday Talk: Still Flying
May 07, 2024
Tickers
AAPL
BABA
PFE
TSLA
Tags
Market News
Energy
Consumer Goods
From
TalkMarkets
Chart Of The Day: ADMA Biologics - Hitting New Highs
May 06, 2024
Tickers
ADMA
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Why Intellia Therapeutics, Inc. Outpaced the Stock Market
May 05, 2024
Tickers
NTLA
Tags
Pharma/Biotech
Market News
From
TalkMarkets
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
May 05, 2024
Tickers
ABCL
ABSI
ATAI
CMPS
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Market Fluctuates Amid Fed Decision And Mixed Corporate Earnings And Economic Signals
May 02, 2024
Tags
Energy
Conglomerates
Futures
From
TalkMarkets
Pfizer Q1 Earnings and Revenues Beat Estimates
May 01, 2024
Tickers
PFE
SPRB
Tags
Market News
Pharma/Biotech
From
TalkMarkets
TG Therapeutics stock just rallied 30%: what happened?
May 01, 2024
Tickers
TGTX
Tags
Pharma/Biotech
Market News
From
TalkMarkets
Market Reversal Alert: Unveiling A Strategic Trading Plan From The Resistance Zone
May 01, 2024
Tickers
REVG
SOXS
SPX
TECS
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
April 28, 2024
Tickers
AZN
JNJ
MRK
NVS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week
April 23, 2024
Tickers
ABCL
ABSI
ATAI
GHRS
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Sweet Nektar?
April 22, 2024
Tickers
NKTR
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Tickers
ABT
IBB
JNJ
LLY
Tags
Market News
Healthcare
Pharma/Biotech
From
TalkMarkets
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
April 15, 2024
Tickers
ABCL
ATAI
CMPS
EXAI
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Alvotech's Share Price At A Critical Juncture
April 13, 2024
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Viking Therapeutics: Strong Results In Obesity
April 13, 2024
Tickers
NVO
VKTX
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
Largest Psychedelic Drug Stocks Up Another 10% Last Week; Now Up 54% YTD
April 12, 2024
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
MicroMarvel - Atossa Therapeutics
April 06, 2024
Tickers
ATOS
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion
April 06, 2024
Tickers
ASND
BMY
CHSYF
GMAB
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Tuesday Talk: April Is The Cruelest Month?
April 02, 2024
Tickers
ADM
BITCOMP
IWM
MU
Tags
ETFs
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Healthcare And Biotech Stocks Review: Q1 2024 Performance
April 01, 2024
Tickers
IBB
PFE
UNH
XBI
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.